Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $7.8100 (-3.58%) ($7.8100 - $8.1100) on Thu. Jan. 19, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.66% (three month average) | RSI | 47 | Latest Price | $7.8100(-3.58%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.7% a day on average for past five trading days. | Weekly Trend | EDIT declines -2.7% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(69%) IBB(55%) IWC(52%) IWM(48%) IWO(48%) | Factors Impacting EDIT price | EDIT will decline at least -2.33% in a week (0% probabilities). VIXM(-16%) SMH(-8%) UUP(-7%) TBT(-6%) GLD(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.33% (StdDev 4.66%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-0.17(-102.18%) | Resistance Level | $8.63 | 5 Day Moving Average | $8.3(-5.9%) | 10 Day Moving Average | $8.43(-7.35%) | 20 Day Moving Average | $8.63(-9.5%) | To recent high | -41% | To recent low | 0% | Market Cap | $485m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |